
Longevity
AGI Surgery Boosts Precision 35% in Longevity Trials
Johns Hopkins AGI surgery trial shows 35% precision gains in longevity therapies. VC funding hits $2.5B as medtech surges amid crypto volatility.
Loading...

Johns Hopkins AGI surgery trial shows 35% precision gains in longevity therapies. VC funding hits $2.5B as medtech surges amid crypto volatility.










